Effectivity of alternative adjuvants in comparison to Freund's complete adjuvant

Main Article Content

Christine Schwarzkopf, Bernhard Thiele
[show affiliations]


In order to replace the use of mammals for the production of hyperimmune sera and to replace Freund's complete adjuvant (FCA) with its undesirable side effects, the production and immunological features of IgY were investigated systematically. An important advantage of IgY is that large amounts can easily be extracted from the yolk of immunised laying hens. With special regard to animal welfare, several biocompatible adjuvants (ABM system, Gerbu adjuvant, TiterMax) were tested with FCA for their usage and effectiveness in the immunisation of chicken. Under appropriate immunisation schedules which strictly avoid intramuscular administration, IgY antibodies with very high titres and a strong binding capacity (avidity) comparable to rabbit hyperimmune sera can be obtained with minimal adjuvant side effects.

Article Details

How to Cite
Schwarzkopf, C. and Thiele, B. (1996) “Effectivity of alternative adjuvants in comparison to Freund’s complete adjuvant”, ALTEX - Alternatives to animal experimentation, 13(Supp. 1), pp. 22–25. Available at: https://www.altex.org/index.php/altex/article/view/2056 (Accessed: 30 May 2024).

Most read articles by the same author(s)